<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:npr="https://www.npr.org/rss/" xmlns:nprml="https://api.npr.org/nprml" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:media="http://search.yahoo.com/mrss/" version="2.0">
  <channel>
    <title>Coronavirus Updates : NPR</title>
    <link>https://www.npr.org/sections/coronavirus-live-updates/</link>
    <description>The latest developments in the COVID-19 pandemic.</description>
    <language>en</language>
    <copyright>Copyright 2021 NPR - For Personal Use Only</copyright>
    <generator>NPR API RSS Generator 0.94</generator>
    <lastBuildDate>Thu, 22 Apr 2021 12:33:18 -0400</lastBuildDate>
    <image>
      <url>https://media.npr.org/images/podcasts/primary/npr_generic_image_300.jpg?s=200</url>
      <title>Coronavirus Updates</title>
      <link>https://www.npr.org/sections/coronavirus-live-updates/</link>
    </image>
    <item>
      <title>U.S. Issues More Than 115 'Do Not Travel' Advisories, Citing Risks From COVID-19</title>
      <description>Just a week ago, only 33 countries were on the U.S. Do Not Travel list. New additions include Canada, Mexico, Germany, the U.K., and dozens of other countries.</description>
      <pubDate>Thu, 22 Apr 2021 12:33:18 -0400</pubDate>
      <link>https://www.npr.org/sections/coronavirus-live-updates/2021/04/22/989809103/u-s-issues-more-than-115-do-not-travel-advisories-citing-risks-from-covid-19</link>
      <guid>https://www.npr.org/sections/coronavirus-live-updates/2021/04/22/989809103/u-s-issues-more-than-115-do-not-travel-advisories-citing-risks-from-covid-19</guid>
      <content:encoded><![CDATA[<img src='https://media.npr.org/assets/img/2021/04/22/ap21032430509061_wide-fa3632dafffd9f1f2e7485c9a66ed9a6d2b53fb1.jpg?s=600' alt='The U.S. has updated its travel advisory list with more than 115 new warnings, as countries in Europe, Asia, South America and elsewhere see new waves of infection. Here, passengers from Taiwan wear protective gear as they arrive at France's Charles de Gaulle Airport north of Paris earlier this year.'/><p>Just a week ago, only 33 countries were on the U.S. Do Not Travel list. New additions include Canada, Mexico, Germany, the U.K., and dozens of other countries.</p><p>(Image credit: Francois Mori/AP)</p><img src='https://media.npr.org/include/images/tracking/npr-rss-pixel.png?story=989809103&p=816541428' />]]></content:encoded>
      <dc:creator>Bill Chappell</dc:creator>
    </item>
    <item>
      <title>FDA Inspection Finds Numerous Problems At Facility Intended To Make J&amp;J Vaccine</title>
      <description>The report on Emergent BioSolutions' Baltimore factory found an array of problems, from peeling paint to inadequate measures to prevent cross-contamination. Manufacturing at the facility is on hold.</description>
      <pubDate>Wed, 21 Apr 2021 14:16:00 -0400</pubDate>
      <link>https://www.npr.org/sections/coronavirus-live-updates/2021/04/21/989549809/fda-inspection-finds-numerous-problems-at-facility-intended-to-make-j-j-vaccine</link>
      <guid>https://www.npr.org/sections/coronavirus-live-updates/2021/04/21/989549809/fda-inspection-finds-numerous-problems-at-facility-intended-to-make-j-j-vaccine</guid>
      <content:encoded><![CDATA[<img src='https://media.npr.org/assets/img/2021/04/21/emergent-biosolutions_wide-4cb279a905ed4e0a9e365f1deb1e1352e5da3412.jpg?s=600' alt='The Emergent BioSolutions Bayview Campus plant in Baltimore has stopped producing vaccine material following an FDA inspection that found numerous problems. The plant was slated to become part of the Johnson & Johnson COVID-19 vaccine production process.'/><p>The report on Emergent BioSolutions' Baltimore factory found an array of problems, from peeling paint to inadequate measures to prevent cross-contamination. Manufacturing at the facility is on hold.</p><p>(Image credit: Tasos Katopodis/Getty Images)</p><img src='https://media.npr.org/include/images/tracking/npr-rss-pixel.png?story=989549809&p=816541428' />]]></content:encoded>
      <dc:creator>Laurel Wamsley</dc:creator>
    </item>
    <item>
      <title>Masks Remain Extremely Effective Indoors, But Are They Necessary Outside?</title>
      <description>Unless people are packed together, "there really just is not much spread happening outdoors," Dr. Ashish Jha of Brown University's School of Public Health says. </description>
      <pubDate>Wed, 21 Apr 2021 13:30:00 -0400</pubDate>
      <link>https://www.npr.org/sections/coronavirus-live-updates/2021/04/21/989104800/masks-remain-extremely-effective-indoors-but-are-they-necessary-outside</link>
      <guid>https://www.npr.org/sections/coronavirus-live-updates/2021/04/21/989104800/masks-remain-extremely-effective-indoors-but-are-they-necessary-outside</guid>
      <content:encoded><![CDATA[<img src='https://media.npr.org/assets/img/2021/04/20/gettyimages-1211881840_wide-9ea47e63bb5f7f62453f0f84a073e43195f5d0d0.jpg?s=600' alt='Most evidence points to the risks of coronavirus transmission outdoors as very low, according to Dr. Ashish Jha of Brown University's School of Public Health.'/><p>Unless people are packed together, "there really just is not much spread happening outdoors," Dr. Ashish Jha of Brown University's School of Public Health says. </p><p>(Image credit: Karen Ducey/Getty Images)</p><img src='https://media.npr.org/include/images/tracking/npr-rss-pixel.png?story=989104800&p=816541428' />]]></content:encoded>
      <dc:creator>Mary Louise Kelly</dc:creator>
    </item>
    <item>
      <title>EU Regulator: 'Possible Link' Between Johnson &amp; Johnson Vaccine And Rare Blood Clots</title>
      <description>While emphasizing that the risk is low, the health agency said there should be a warning about the rare condition included in the product information for the vaccine.</description>
      <pubDate>Tue, 20 Apr 2021 13:24:00 -0400</pubDate>
      <link>https://www.npr.org/sections/coronavirus-live-updates/2021/04/20/989149900/eu-regulator-possible-link-between-johnson-johnson-vaccine-and-rare-blood-clots</link>
      <guid>https://www.npr.org/sections/coronavirus-live-updates/2021/04/20/989149900/eu-regulator-possible-link-between-johnson-johnson-vaccine-and-rare-blood-clots</guid>
      <content:encoded><![CDATA[<img src='https://media.npr.org/assets/img/2021/04/20/gettyimages-1232332153-1-_wide-c9354c0e73a1266aa995a49c05e55141c9a49022.jpg?s=600' alt='Boxes containing the Johnson & Johnson COVID-19 vaccine, developed by the company's Janssen Pharmaceuticals unit, are shown at a vaccination center in Los Angeles last week.'/><p>While emphasizing that the risk is low, the health agency said there should be a warning about the rare condition included in the product information for the vaccine.</p><p>(Image credit: Allen J. Schaben/Los Angeles Times via Getty Images)</p><img src='https://media.npr.org/include/images/tracking/npr-rss-pixel.png?story=989149900&p=816541428' />]]></content:encoded>
      <dc:creator>Scott Neuman</dc:creator>
    </item>
    <item>
      <title>State Department To Issue Travel Warnings Amid 'Unprecedented' COVID-19 Risks</title>
      <description>The department says the new advisories will "better reflect the Centers for Disease Control and Prevention's science." Americans are urged not to travel to nearly 80% of countries around the globe. </description>
      <pubDate>Mon, 19 Apr 2021 20:20:14 -0400</pubDate>
      <link>https://www.npr.org/sections/coronavirus-live-updates/2021/04/19/988940638/state-department-to-issue-travel-warnings-amid-unprecedented-covid-19-risks</link>
      <guid>https://www.npr.org/sections/coronavirus-live-updates/2021/04/19/988940638/state-department-to-issue-travel-warnings-amid-unprecedented-covid-19-risks</guid>
      <content:encoded><![CDATA[<img src='https://media.npr.org/assets/img/2021/04/19/gettyimages-77646654_wide-b87d2485f646ce6d0078be280a167569da3f818e.jpg?s=600' alt='The U.S. Department of State will add a slew of countries to its "Do Not Travel List" later this week because of coronavirus danger.'/><p>The department says the new advisories will "better reflect the Centers for Disease Control and Prevention's science." Americans are urged not to travel to nearly 80% of countries around the globe. </p><p>(Image credit: Paul J. Richards/AFP via Getty Images)</p><img src='https://media.npr.org/include/images/tracking/npr-rss-pixel.png?story=988940638&p=816541428' />]]></content:encoded>
      <dc:creator>Vanessa Romo</dc:creator>
    </item>
    <item>
      <title>Joy, Relief In Airports As Australia And New Zealand Open 'Travel Bubble'</title>
      <description>Families and friends met in airports for the first time in over a year after Australia and New Zealand opened a "bubble" of quarantine-free travel between their countries.</description>
      <pubDate>Mon, 19 Apr 2021 17:45:58 -0400</pubDate>
      <link>https://www.npr.org/sections/coronavirus-live-updates/2021/04/19/988857027/joy-relief-in-airports-as-australia-and-new-zealand-open-travel-bubble</link>
      <guid>https://www.npr.org/sections/coronavirus-live-updates/2021/04/19/988857027/joy-relief-in-airports-as-australia-and-new-zealand-open-travel-bubble</guid>
      <content:encoded><![CDATA[<img src='https://media.npr.org/assets/img/2021/04/19/gettyimages-1232393379_wide-dd172d56ce011ac3a71b48b4dd883b0542e1529c.jpg?s=600' alt='Families are reunited as travelers arrive on the first flight from Sydney in Wellington on Monday after Australia and New Zealand opened a trans-Tasman quarantine-free travel bubble.'/><p>Families and friends met in airports for the first time in over a year after Australia and New Zealand opened a "bubble" of quarantine-free travel between their countries.</p><p>(Image credit: Marty Melville/AFP via Getty Images)</p><img src='https://media.npr.org/include/images/tracking/npr-rss-pixel.png?story=988857027&p=816541428' />]]></content:encoded>
      <dc:creator>Ashley Westerman </dc:creator>
    </item>
    <item>
      <title>Global COVID-19 Deaths Top 3 Million </title>
      <description>The largest number of deaths have come in the United States, Brazil, Mexico, India and the United Kingdom. The pandemic death toll reached 1 million in September 2020 and 2 million in January.</description>
      <pubDate>Sat, 17 Apr 2021 14:59:15 -0400</pubDate>
      <link>https://www.npr.org/sections/coronavirus-live-updates/2021/04/17/988386358/global-covid-19-deaths-top-3-million</link>
      <guid>https://www.npr.org/sections/coronavirus-live-updates/2021/04/17/988386358/global-covid-19-deaths-top-3-million</guid>
      <content:encoded><![CDATA[<img src='https://media.npr.org/assets/img/2021/04/17/gettyimages-1232332886_wide-d8eac6815c26ce5e9128431ef08aadfb72ba653c.jpg?s=600' alt='Relatives attend a COVID-19 victim's burial at a cemetery in Manaus, Amazonas state, Brazil, on Thursday.'/><p>The largest number of deaths have come in the United States, Brazil, Mexico, India and the United Kingdom. The pandemic death toll reached 1 million in September 2020 and 2 million in January.</p><p>(Image credit: Michael Dantas/Getty Images)</p><img src='https://media.npr.org/include/images/tracking/npr-rss-pixel.png?story=988386358&p=816541428' />]]></content:encoded>
      <dc:creator>Jeannette Muhammad</dc:creator>
    </item>
    <item>
      <title>Ex-FDA Chief Sees 'Struggle' To Vaccinate More Than Half U.S. Population</title>
      <description>Dr. Scott Gottlieb doesn't expect enough demand for the vaccine much beyond 160 million Americans. But he says there may eventually be enough immunity to curb the spread of the coronavirus.</description>
      <pubDate>Wed, 14 Apr 2021 16:00:58 -0400</pubDate>
      <link>https://www.npr.org/sections/coronavirus-live-updates/2021/04/14/987265125/ex-fda-chief-sees-struggle-to-vaccinate-more-than-half-u-s-population</link>
      <guid>https://www.npr.org/sections/coronavirus-live-updates/2021/04/14/987265125/ex-fda-chief-sees-struggle-to-vaccinate-more-than-half-u-s-population</guid>
      <content:encoded><![CDATA[<img src='https://media.npr.org/assets/img/2021/04/14/gettyimages-866274648_wide-6c4a054eaaaf041329df5af3ae10359e8fb26883.jpg?s=600' alt='Dr. Scott Gottlieb, then commissioner of the Food and Drug Administration, testifies during a House hearing on in October 2017. In an NPR interview, Gottlieb says he doesn't expect enough demand for the COVID-19 vaccine much beyond 160 million Americans.'/><p>Dr. Scott Gottlieb doesn't expect enough demand for the vaccine much beyond 160 million Americans. But he says there may eventually be enough immunity to curb the spread of the coronavirus.</p><p>(Image credit: Drew Angerer/Getty Images)</p><img src='https://media.npr.org/include/images/tracking/npr-rss-pixel.png?story=987265125&p=816541428' />]]></content:encoded>
      <dc:creator>Steve Inskeep</dc:creator>
    </item>
    <item>
      <title>Denmark Drops AstraZeneca Vaccine, Citing Rare Side Effects, Epidemic 'Under Control'</title>
      <description>The Danish Health Authority said it will continue its vaccination campaign without the shot made by AstraZeneca, but said its benefits outweigh the risks for those who do get it.</description>
      <pubDate>Wed, 14 Apr 2021 14:22:00 -0400</pubDate>
      <link>https://www.npr.org/sections/coronavirus-live-updates/2021/04/14/987166681/denmark-drops-astrazeneca-vaccine-citing-rare-side-effects-epidemic-under-contro</link>
      <guid>https://www.npr.org/sections/coronavirus-live-updates/2021/04/14/987166681/denmark-drops-astrazeneca-vaccine-citing-rare-side-effects-epidemic-under-contro</guid>
      <content:encoded><![CDATA[<img src='https://media.npr.org/assets/img/2021/04/14/gettyimages-1231888707_wide-fde89e3fb5f9e4f54588d651b9ae8e591a4cdacd.jpg?s=600' alt='Danish health authorities announced Wednesday that the country will continue its COVID-19 vaccine rollout without the shot made by AstraZeneca, citing its possible link to rare blood clotting events, the availability of other vaccines and the "fact that the COVID-19 epidemic in Denmark is currently under control."'/><p>The Danish Health Authority said it will continue its vaccination campaign without the shot made by AstraZeneca, but said its benefits outweigh the risks for those who do get it.</p><p>(Image credit: Dirk Waem/BELGA MAG/AFP via Getty Images)</p><img src='https://media.npr.org/include/images/tracking/npr-rss-pixel.png?story=987166681&p=816541428' />]]></content:encoded>
      <dc:creator>Rachel Treisman</dc:creator>
    </item>
    <item>
      <title>CDC, FDA To Review J&amp;J Shot After 6 Blood Clot Cases Reported Out Of Nearly 7M Doses</title>
      <description>In a statement on Tuesday, U.S. authorities said they are "reviewing data involving six reported U.S. cases of a rare and severe type of blood clot in individuals after receiving the J&amp;J vaccine."</description>
      <pubDate>Tue, 13 Apr 2021 07:51:42 -0400</pubDate>
      <link>https://www.npr.org/sections/coronavirus-live-updates/2021/04/13/986709618/u-s-recommends-pausing-use-of-johnson-johnson-vaccine-over-blood-clot-concerns</link>
      <guid>https://www.npr.org/sections/coronavirus-live-updates/2021/04/13/986709618/u-s-recommends-pausing-use-of-johnson-johnson-vaccine-over-blood-clot-concerns</guid>
      <content:encoded><![CDATA[<img src='https://media.npr.org/assets/img/2021/04/13/ap21065661043422_wide-44935c09b34b93a7823fac220ff1ffdb04fb5765.jpg?s=600' alt='The U.S. Food and Drug Administration and the Centers for Disease Control and Prevention have recommended a pause in the use of the Johnson & Johnson COVID-19 vaccine, shown here in a hospital in Denver.'/><p>In a statement on Tuesday, U.S. authorities said they are "reviewing data involving six reported U.S. cases of a rare and severe type of blood clot in individuals after receiving the J&J vaccine."</p><p>(Image credit: David Zalubowski/AP)</p><img src='https://media.npr.org/include/images/tracking/npr-rss-pixel.png?story=986709618&p=816541428' />]]></content:encoded>
      <dc:creator>Scott Neuman</dc:creator>
    </item>
    <item>
      <title>Millions Flock To Hindu Festival Amid Coronavirus Spike</title>
      <description>Hindu pilgrims are traveling to bathe in the Ganges River to wipe out their sins.</description>
      <pubDate>Tue, 13 Apr 2021 05:52:00 -0400</pubDate>
      <link>https://www.npr.org/sections/coronavirus-live-updates/2021/04/13/986686352/millions-flock-to-hindu-festival-amid-coronavirus-spike</link>
      <guid>https://www.npr.org/sections/coronavirus-live-updates/2021/04/13/986686352/millions-flock-to-hindu-festival-amid-coronavirus-spike</guid>
      <content:encoded><![CDATA[<img src='https://media.npr.org/assets/img/2021/04/13/gettyimages-1231661122_wide-8a0d29a5a7f552e8c9058fbd909e958a1c1521f0.jpg?s=600' alt='Men take a holy dip in the Ganges River on the occasion of first royal bath of Shivratri festival during Maha Kumbh Festival in Haridwar, India.'/><p>Hindu pilgrims are traveling to bathe in the Ganges River to wipe out their sins.</p><p>(Image credit: Ritesh Shukla/NurPhoto via Getty Images)</p><img src='https://media.npr.org/include/images/tracking/npr-rss-pixel.png?story=986686352&p=816541428' />]]></content:encoded>
      <dc:creator>Sushmita Pathak</dc:creator>
    </item>
    <item>
      <title>U.K. Coronavirus Strain Does Not Lead To More Severe Illness And Death, Study Finds</title>
      <description>The B.1.1.7 variant is now the most dominant version of the coronavirus in the U.S.</description>
      <pubDate>Tue, 13 Apr 2021 02:26:00 -0400</pubDate>
      <link>https://www.npr.org/sections/coronavirus-live-updates/2021/04/13/986647390/u-k-coronavirus-strain-does-not-lead-to-more-severe-illness-and-death-study-find</link>
      <guid>https://www.npr.org/sections/coronavirus-live-updates/2021/04/13/986647390/u-k-coronavirus-strain-does-not-lead-to-more-severe-illness-and-death-study-find</guid>
      <content:encoded><![CDATA[<img src='https://media.npr.org/assets/img/2021/04/13/gettyimages-1231994905_wide-910e6f7f56e548f5d4a57f3f3fd082ee1edbfa38.jpg?s=600' alt='Hospital workers tend to a Covid-19 patient at Queen Alexandra Hospital in Portsmouth, England, last month. Researchers have found that the so-called U.K. variant of the coronavirus isn't more likely to lead to death or severe illness.'/><p>The B.1.1.7 variant is now the most dominant version of the coronavirus in the U.S.</p><p>(Image credit: Adrian Dennis/AFP via Getty Images)</p><img src='https://media.npr.org/include/images/tracking/npr-rss-pixel.png?story=986647390&p=816541428' />]]></content:encoded>
      <dc:creator>Jaclyn Diaz</dc:creator>
    </item>
    <item>
      <title>The Country That Vaccinated 93% Of Adults In Under 2 Weeks</title>
      <description>Just 12 days after Bhutan launched a nationwide vaccination campaign on March 27, health officials said 93% of eligible adults had received one dose of AstraZeneca's COVID-19 vaccine.</description>
      <pubDate>Mon, 12 Apr 2021 16:25:26 -0400</pubDate>
      <link>https://www.npr.org/sections/coronavirus-live-updates/2021/04/12/986450910/the-advantage-of-our-smallness-bhutan-vaccinates-93-of-adults-in-under-2-weeks</link>
      <guid>https://www.npr.org/sections/coronavirus-live-updates/2021/04/12/986450910/the-advantage-of-our-smallness-bhutan-vaccinates-93-of-adults-in-under-2-weeks</guid>
      <content:encoded><![CDATA[<img src='https://media.npr.org/assets/img/2021/04/12/gettyimages-1231957928_wide-a589db02b7ac4a6f1aebfa049eb09a61afcbfd62.jpg?s=600' alt='A health worker vaccinates a Buddhist monk sitting in front of a portrait of Bhutanese King Jigme Khesar Namgyel Wangchuck at a secondary school in Bhutan on March 27, the first day of the country's vaccination campaign. Less than two weeks later, health officials said 93% of eligible adults had received their first dose of a COVID-19 vaccine.'/><p>Just 12 days after Bhutan launched a nationwide vaccination campaign on March 27, health officials said 93% of eligible adults had received one dose of AstraZeneca's COVID-19 vaccine.</p><p>(Image credit: Upasana Dahal/AFP via Getty Images)</p><img src='https://media.npr.org/include/images/tracking/npr-rss-pixel.png?story=986450910&p=816541428' />]]></content:encoded>
      <dc:creator>Rachel Treisman</dc:creator>
    </item>
    <item>
      <title>Studies Confirm Racial, Ethnic Disparities In COVID-19 Hospitalizations And Visits</title>
      <description>Two new Centers for Disease Control and Prevention studies shed additional light on the disproportionate impact of COVID-19 on communities of color, with implications for vaccine distribution. </description>
      <pubDate>Mon, 12 Apr 2021 16:01:57 -0400</pubDate>
      <link>https://www.npr.org/sections/coronavirus-live-updates/2021/04/12/986513859/studies-confirm-racial-ethnic-disparities-in-covid-19-hospitalizations-and-visit</link>
      <guid>https://www.npr.org/sections/coronavirus-live-updates/2021/04/12/986513859/studies-confirm-racial-ethnic-disparities-in-covid-19-hospitalizations-and-visit</guid>
      <content:encoded><![CDATA[<img src='https://media.npr.org/assets/img/2021/04/12/gettyimages-1210583584_wide-cd339b5261dccb1fecde0679774ce9a3d6341e36.jpg?s=600' alt='Two Centers for Disease Control and Prevention studies released Monday shed new light on the racial and ethnic disparities in hospitalizations and emergency visits related to COVID-19 last year.'/><p>Two new Centers for Disease Control and Prevention studies shed additional light on the disproportionate impact of COVID-19 on communities of color, with implications for vaccine distribution. </p><p>(Image credit: Blake Nissen/Boston Globe via Getty Images)</p><img src='https://media.npr.org/include/images/tracking/npr-rss-pixel.png?story=986513859&p=816541428' />]]></content:encoded>
      <dc:creator>Rachel Treisman</dc:creator>
    </item>
    <item>
      <title>Germany Says It Will Explore Buying Russia's Sputnik V Vaccine, Bucking EU Policy</title>
      <description>Health Minister Jens Spahn said Sputnik V could be a stop-gap solution to Europe's critical COVID-19 vaccine shortage. Spahn said Germany will still wait for EU regulators to approve the vaccine.</description>
      <pubDate>Thu, 08 Apr 2021 13:03:00 -0400</pubDate>
      <link>https://www.npr.org/2021/04/08/985410735/germany-says-it-will-explore-buying-russias-sputnik-v-vaccine-bucking-eu-policy</link>
      <guid>https://www.npr.org/2021/04/08/985410735/germany-says-it-will-explore-buying-russias-sputnik-v-vaccine-bucking-eu-policy</guid>
      <content:encoded><![CDATA[<img src='https://media.npr.org/assets/img/2021/04/08/ap21090361475433_wide-709a988e0bc3fbaa2630c972ad755f52cc35a75c.jpg?s=600' alt='People wait in front of the vaccination center in Gelsenkirchen, Germany, Wednesday, last week. Germany's health minister says the country is exploring purchasing the Sputnik V COVID-19 vaccine from Russia.'/><p>Health Minister Jens Spahn said Sputnik V could be a stop-gap solution to Europe's critical COVID-19 vaccine shortage. Spahn said Germany will still wait for EU regulators to approve the vaccine.</p><p>(Image credit: Martin Meissner/AP)</p><img src='https://media.npr.org/include/images/tracking/npr-rss-pixel.png?story=985410735&p=816541428' />]]></content:encoded>
      <dc:creator>Esme Nicholson</dc:creator>
    </item>
  </channel>
</rss>
